Lv3
330 积分 2024-06-15 加入
Notch1 activation and inhibition in T-cell acute lymphoblastic leukemia subtypes
18天前
已关闭
A phase I clinical trial of the notch inhibitor MK-0752 in patients with T-cell acute lymphoblastic leukemia/lymphoma (T-ALL) and other leukemias
18天前
已关闭
T‐cell lymphoblastic lymphoma in children, adolescents and young adults
18天前
已完结
Novel insights of acute myeloid leukemia with CEBPA deregulation: Heterogeneity dissection and re-stratification
1个月前
已完结
Targeting BET proteins improves the therapeutic efficacy of BCL-2 inhibition in T-cell acute lymphoblastic leukemia
2个月前
已关闭
The role of nelarabine in the treatment of T-cell acute lymphoblastic leukemia/lymphoma: challenges, opportunities, and future directions
2个月前
已完结
Nelarabine: when and how to use in the treatment of T-cell acute lymphoblastic leukemia
2个月前
已完结
Longitudinal follow up of a phase 2 trial of venetoclax added to hyper-CVAD, nelarabine and pegylated asparaginase in patients with T-cell acute lymphoblastic leukemia and lymphoma
3个月前
已完结
Venetoclax plus azacitidine in relapsed or refractory T-cell acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 trial
3个月前
已完结
Genetic and Epigenetic Profiles in T-ALL
4个月前
已完结
皖公网安备34019202002308
